03
Sun, Dec
68 New Articles

Deal 5: MediGroup Director Mihailo Obucina on Acquisition of Konzilijum

Deal 5: MediGroup Director Mihailo Obucina on Acquisition of Konzilijum

Serbia
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

On December 8, CEE Legal Matters reported that BDK Advokati had advised MediGroup on its acquisition of Konzilijum. CEE In-House Matters spoke with Mihailo Obucina, Director of Strategy, M&A, and Business Development at MediGroup, to learn more about the acquisition.

CEEIHM: To start, tell us about MediGroup and its operations in Serbia

Obucina: MediGroup is the largest fully integrated private medical system in Serbia, having one general hospital, two special hospitals, 12 health centers, four imaging centers, and 77 blood collection points with more than 1,600 full-time employees and 1,000 consultants. We are the only privately held healthcare provider with professional management and a national presence in the four largest cities. The majority of the company is owned by the PE fund MidEuropa Partners, based in the UK.

CEEIHM: You were recently advised on the acquisition of Konzilijum. What made the target appealing for you?

Obucina: Market leadership, strong reputation, and medical quality since Konzilijum is recognized as the best laboratory in the country both by our patients and the medical community. This is our third acquisition in this sub-segment over the past four years and we managed to achieve one of our strategic objectives to become the #1 medical laboratory in all aspects (revenue, number of tests, number of locations, number of employees, etc.).

CEEIHM: What was the most complex aspect of this deal from a legal perspective?

Obucina: The deal structure was complex due to the equity/asset carveouts which had to be completed within a very limited timeframe and healthcare legislation which was challenging to navigate through.

CEEIHM: How was the legal work split between your in-house legal team and that of BDK’s?

Obucina: We consider BDK as a thorough partner throughout the process and there is no clear line between them and our legal team. BDK was fully involved in all aspects of the transaction, from legal due diligence until closing.

CEEIHM: Lastly, why did you pick BDK to advise you on this matter?

Obucina: Expertise, flexibility, and previous experience in the healthcare sector, as this is the sixth acquisition for MediGroup since 2018 that we completed together with BDK as our legal advisors.

Originally reported by CEE In-House Matters.

Serbia Knowledge Partner

Committed to redefining a law firm's role in an emerging regional market, Gecić Law is a full-service law firm that advises international and local clients from the public and private sectors in navigating the complex legal landscape of the region across multiple practice areas. Members of the Gecić Law team have graduated from leading universities in the US and Europe. They have extensive local and international experience, with a particular focus on EU regulatory frameworks and international trade and a proven track record in providing innovative and practical solutions in the most complex of matters.

Gecić Law is an exclusive member of two leading global alliances, TerraLex and TAGLaw, extending its international footprint. The firm and its lawyers have continuously been recognized in several practice areas by elite global directories, including The Legal 500, Chambers and Partners and Benchmark Litigation. Gecić Law was named Law Firm of the Year: South Eastern Europe 2021 and Law Firm of the Year: Eastern Europe and the Balkans 2020 at The Lawyer European Awards and was repeatedly nominated in other practice areas.

For more details, please visit geciclaw.com.

 

Our Latest Issue